HF
APTO

HRT Financial’s Aptose Biosciences, Inc. APTO Stock Holding History

HRT Financial’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,437
Closed -$9K – 3629
2024
Q4 		$9K Buy
+1,437
New +$13.1K ﹤0.01% 2298
2022
Q1 		– Sell
-29
Closed -$17K – 4118
2021
Q4 		$17K Buy
+29
New +$27.3K ﹤0.01% 2973

Other funds holding APTO

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

HRT Financial's APTO Position: Q1 2025 in Review

HRT Financial sold out of Aptose Biosciences, Inc. (APTO) in Q1 2025, closing a stake of 1,437 shares — an estimated $9K sold.

HRT Financial first reported a position in APTO in Q4 2021 and held it in 2 quarters. The position peaked at $17K in Q4 2021. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2025.

  • HRT Financial reported no remaining Aptose Biosciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 1,437 Aptose Biosciences, Inc. shares in Q1 2025, an estimated $9K.
  • HRT Financial first reported a position in Aptose Biosciences, Inc. in Q4 2021 and held it in 2 quarters.
  • HRT Financial's Aptose Biosciences, Inc. position peaked at $17K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.